- Investing Ideas
- Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
5
High return on equity, past performance and sound balance sheet.
5 companies
Sanofi Consumer Healthcare India
Market Cap: ₹105.5b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,580.30
7D
-2.5%
1Y
-7.3%
Sanofi India
Market Cap: ₹80.6b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,501.40
7D
-0.6%
1Y
-45.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹417.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,462.75
7D
2.3%
1Y
-13.6%
Abbott India
Market Cap: ₹540.0b
Operates as a pharmaceutical company in India.
500488
₹25,414.45
7D
-2.1%
1Y
-16.5%
Blue Jet Healthcare
Market Cap: ₹72.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹416.85
7D
2.1%
1Y
-44.1%